Home » Topics » BioWorld Science

BioWorld Science
RSS

Ahammune Biosciences discloses compounds for celiac disease

March 25, 2019

Insight into the metabolic-epigenetic interplay of fumaric acid esters in brain-homing T cells in MS

March 25, 2019

Lead Pharma initiates phase I study of SAR-441169

March 25, 2019

VLP Therapeutics initiates phase I study of VLPM-01 vaccine

March 25, 2019

BioInvent discloses a program to target TNFR2 for the treatment of solid tumors

March 25, 2019

Nuformix begins clinical trial of NXP-001 for CINV

March 22, 2019

GATA-3 is a new biomarker of gonadotroph adenomas

March 22, 2019

AZGP1 is correlated with HPV positivity in oropharyngeal squamous cell carcinoma

March 22, 2019

Unusual anti-inflammatory meroterpenoids isolated from the marine sponge Dysidea septosa

March 22, 2019

Sihuan demonstrates proof of mechanism with CDK4/6 inhibitor birociclib in phase I

March 22, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
Tuojie Biotech (Shanghai) synthesizes new SARM1 inhibitors
BioWorld Science
Tuojie Biotech (Shanghai) Co. Ltd. has prepared and tested NAD(+) hydrolase SARM1 (SAMD2; MyD88-5) inhibitors found to be potentially useful for the treatment of...
Death in Chinese gene-editing trial exposes ethical fault lines
BioWorld
The death of a 6-year-old girl after receiving an experimental brain-directed gene-editing therapy at the Xinhua Hospital in Shanghai has reopened debate over how...
Seed funding at Adjuvia to treat mitochondrial dysfunction
BioWorld Science
Adjuvia Therapeutics Inc. has closed a $8 million series seed financing round to advance its work developing therapeutics to treat mitochondrial dysfunction and...
Replimune’s RP-1 for melanoma wins over FDA adcom
BioWorld
Following two complete response letters in the past year, Replimune Group Inc.’s RP-1 (suvolimogene oderparepvec) for unresectable metastatic cutaneous melanoma...